SANA BIOTECHNOLOGY INC (SANA) Stock Income Statement
NASDAQ:SANA - Nasdaq - US7995661045 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 207.63M | 272.72M | 293.14M | 272.56M | 356.91M | |||
| Research and Development | 198.31M | 217.56M | 268.82M | 285.89M | 248.63M | |||
| Selling, General, and Administrative Expenses | 59.26M | 64.04M | 73.30M | 71.56M | 50.41M | |||
| Operating Income | -207.63M | -272.72M | -293.14M | -272.56M | -356.91M | |||
| Interest Income/Expense | 8.43M | 10.47M | 9.94M | 3.76M | 680.00K | |||
| Other Income/Expense | -4.47M | -4.51M | -52.00K | -670.00K | 310.00K | |||
| Non Recurring Items | N/A | N/A | N/A | N/A | N/A | |||
| Income Before Taxes | -208.67M | -266.76M | -283.25M | -269.48M | -355.93M | |||
| Income Tax | N/A | N/A | N/A | N/A | 0.00 | |||
| Net Income | -208.67M | -266.76M | -283.25M | -269.48M | -355.93M | |||
| EBITDA | -190.34M | -255.33M | -268.58M | -256.93M | -345.84M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.88 | -1.16 | -1.46 | -1.43 | -2.14 | |||
| Non GAAP EPS | -0.88 | -1.16 | -1.41 | -1.69 | -1.83 | |||
| Statistics | ||||||||
All data in USD